BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 7615097)

  • 1. The transcription factor VAX1 in VIP neurons of the suprachiasmatic nucleus impacts circadian rhythm generation, depressive-like behavior, and the reproductive axis in a sex-specific manner in mice.
    Van Loh BM; Yaw AM; Breuer JA; Jackson B; Nguyen D; Jang K; Ramos F; Ho EV; Cui LJ; Gillette DLM; Sempere LF; Gorman MR; Tonsfeldt KJ; Mellon PL; Hoffmann HM
    Front Endocrinol (Lausanne); 2023; 14():1269672. PubMed ID: 38205198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of ovulation: new insight into an old challenge.
    Maman E; Adashi EY; Baum M; Hourvitz A
    Sci Rep; 2023 Nov; 13(1):20003. PubMed ID: 37968377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human embryo implantation.
    Muter J; Lynch VJ; McCoy RC; Brosens JJ
    Development; 2023 May; 150(10):. PubMed ID: 37254877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Possible Mechanism for Double-Yolked Eggs in the Early Stage of Egg-Laying in Zhedong White Goose-Function of IGF1 and LHR Signaling.
    Liu J; Zhao X; Dai Z; Yang P; Chen R; Guo B; Lei M; Shi Z
    Animals (Basel); 2022 Oct; 12(21):. PubMed ID: 36359088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One follicle, one egg, one embryo: a case-report of successful pregnancy obtained from a single oocyte collected.
    Sciorio R; Angelaki E; Al-Azemi N; Elmardi A
    JBRA Assist Reprod; 2021 Apr; 25(2):314-317. PubMed ID: 33507717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.
    Abbara A; Clarke SA; Dhillo WS
    Endocr Rev; 2018 Oct; 39(5):593-628. PubMed ID: 29982525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Chorionic Gonadotropin: The Pregnancy Hormone and More.
    Theofanakis C; Drakakis P; Besharat A; Loutradis D
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28505106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two human chorionic gonadotropin doses administered to the ovarian states during the
    Ma M; Wang J; Xu L; Zhang Q; DU B; Jiang X; Shi Q; Zhou L; Li B; Saito H; Kurachi H
    Biomed Rep; 2015 Mar; 3(2):215-219. PubMed ID: 26075075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone agonist triggering is effective, even at a low dose, for final oocyte maturation in ART cycles: Case series.
    Gülekli B; Göde F; Sertkaya Z; Işık AZ
    J Turk Ger Gynecol Assoc; 2015; 16(1):35-40. PubMed ID: 25788848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.
    Lehert P; Kolibianakis EM; Venetis CA; Schertz J; Saunders H; Arriagada P; Copt S; Tarlatzis B
    Reprod Biol Endocrinol; 2014 Feb; 12():17. PubMed ID: 24555766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation.
    Drakakis P; Loutradis D; Beloukas A; Sypsa V; Anastasiadou V; Kalofolias G; Arabatzi H; Kiapekou E; Stefanidis K; Paraskevis D; Makrigiannakis A; Hatzakis A; Antsaklis A
    Reprod Biol Endocrinol; 2009 Oct; 7():110. PubMed ID: 19825188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "hCG priming" effect in controlled ovarian stimulation through a long protocol.
    Beretsos P; Partsinevelos GA; Arabatzi E; Drakakis P; Mavrogianni D; Anagnostou E; Stefanidis K; Antsaklis A; Loutradis D
    Reprod Biol Endocrinol; 2009 Aug; 7():91. PubMed ID: 19719843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of luteinizing hormone activity in controlled ovarian stimulation.
    Angelopoulos N; Goula A; Tolis G
    J Endocrinol Invest; 2005 Jan; 28(1):79-88. PubMed ID: 15816376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary pharmacological manipulation in assisted reproduction.
    Huirne JA; Lambalk CB; van Loenen AC; Schats R; Hompes PG; Fauser BC; Macklon NS
    Drugs; 2004; 64(3):297-322. PubMed ID: 14871171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles.
    Kovacs P; Barg PE; Witt BR
    J Assist Reprod Genet; 2001 Jul; 18(7):391-4. PubMed ID: 11499324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma levels of hCG after 10,000-IU hCG injection do not reduce the number or maturation of oocytes recovered in patients undergoing assisted reproduction.
    al-Hassan S; Fishel S; Fleming S; Thornton S
    J Assist Reprod Genet; 1998 Nov; 15(10):583-6. PubMed ID: 9866065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The luteinizing hormone surge--the final stage in ovulation induction: modern aspects of ovulation triggering.
    Shoham Z; Schacter M; Loumaye E; Weissman A; MacNamee M; Insler V
    Fertil Steril; 1995 Aug; 64(2):237-51. PubMed ID: 7615097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations of luteinizing hormone serum concentrations after exogenous human chorionic gonadotropin administration during ovarian hyperstimulation.
    Demoulin A; Dubois M; Gerday C; Gillain D; Lambotte R; Franchimont P
    Fertil Steril; 1991 Apr; 55(4):797-804. PubMed ID: 1901284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL; Casper RF; Yen SS
    Am J Obstet Gynecol; 1979 Nov; 135(6):759-63. PubMed ID: 386801
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.